The FTSE 100 company, which has a market capitalisation of £185.9 billion, confirmed the deal in an announcement to the ...
Tallying up a wide range of investments, AstraZeneca said it is pumping $2.5 billion into Beijing. The figure includes ...
1. AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing.
Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results